Degradable cross-linked nanoassemblies as drug carriers for heat shock protein 90 inhibitor 17-N-allylamino-17-demethoxygeldanamycin

Pharmaceuticals

Volumn 4, Issue 10, 2011, Pages 1281-1292

  Ponta, Andrei ^a   Akter, Shanjida ^a   Bae, Younsoo ^a  

^a University of Kentucky   (United States)

Author keywords

Cancer chemotherapy; Controlled drug release; Drug delivery; Heat shock protein 90; Nanoassemblies

Indexed keywords

COPOLYMER; NANOCARRIER; TANESPIMYCIN;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOLECULAR WEIGHT; NANOPHARMACEUTICS; PARTICLE SIZE; PH MEASUREMENT; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 80055098071     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4101281     Document Type: Article

References (26)

1. Chiosis, G.; Neckers, L. Tumor selectivity of hsp90 inhibitors: The explanation remains elusive. ACS Chem. Biol. 2006, 1, 279-284.
2. Ferrarini, M.; Heltai, S.; Zocchi, M.R.; Rugarli, C. Unusual expression and localization of heat-shock proteins in human tumor-cells. Int. J. Cancer 1992, 51, 613-619.
3. Young, J.C.; Moarefi, I.; Hartl, F.U. Hsp90: A specialized but essential protein-folding tool. J. Cell Biol. 2001, 154, 267-273.
4. Hanahan, D.; Olson, P.; Lu, J.; Zhang, H.; Shai, A.; Chun, M.G.; Wang, Y.C.; Libutti, S.K.; Nakakura, E.K.; Golub, T.R. Microrna dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009, 23, 2152-2165.
5. Neckers, L.; Xu, W.P. Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin. Cancer Res. 2007, 13, 1625-1629.
6. Goetz, M.P.; Toft, D.O.; Ames, M.M.; Erlichman, C. The hsp90 chaperone complex as a novel target for cancer therapy. Ann. Oncol. 2003, 14, 1169-1176.
7. Whitesell, L.; Beliakoff, J. Hsp90: An emerging target for breast cancer therapy. Anticancer Drugs 2004, 15, 651-662.
8. Burrows, F.J.; Kamal, A.; Thao, L.; Sensintaffar, J.; Zhang, L.; Boehm, M.F.; Fritz, L.C. A high-affinity conformation of hsp90 confers tumour selectivity on hsp90 inhibitors. Nature 2003, 425, 407-410.
9. Supko, J.G.; Lu, H.; Jimeno, J.M.; Grant, W.; Faircloth, G.T. Preclinical pharmacology studies with the marine natural product kahalalide f. Clin. Cancer Res. 1999, 5, 3792s-3792s.
10. Younes, A.; Copeland, A.R.; Romaguera, J.; Fayad, L.; Fanale, M.; Faria, S.D.; Medeiros, L.J.; Ivy, S.P. Clinical and biologic activity of the heat shock protein-90 (hsp-90) inhibitor 17-aag in patients with relapsed lymphoma. Blood 2009, 114, 1441-1441.
11. Duncan, R.; Ringsdorf, H.; Satchi-Fainaro, R. Polymer therapeutics-polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities. J. Drug Target. 2006, 14, 337-341.
12. Torchilin, V. Tumor delivery of macromolecular drugs based on the epr effect. Adv. Drug Deliv. Rev. 2011, 63, 131-135.
13. Delcea, M.; Möhwald, H.; Skirtach, A.G. Stimuli-responsive lbl capsules and nanoshells for drug delivery. Adv. Drug Deliv. Rev. 2011, 63, 730-747.
14. Lee, H.; Soo, P.L.; Liu, J.; Butler, M.; Allen, C. Polymeric micelles for formulation of anti-cancer drugs. Nanotechnol. Cancer Ther. 2007, 317-355.
15. Bae, Y.; Kataoka, K. Intelligent polymeric micelles from functional poly(ethylene glycol)- poly(amino acid) block copolymers. Adv. Drug Deliv. Rev. 2009, 61, 768-784.
16. Miyata, K.; Christie, R.J.; Kataoka, K. Polymeric micelles for nano-scale drug delivery. React. Funct. Polym. 2011, 71, 227-234.
17. Bae, Y.; Fukushima, S.; Harada, A.; Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular ph change. Angew. Chem. Int. Ed. 2003, 42, 4640-4643.
18. Bae, Y.; Jang, W.-D.; Nishiyama, N.; Fukushima, S.; Kataoka, K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and ph-triggered drug releasing properties for active intracellular drug delivery. Mol. BioSyst. 2005, 1, 242-250.
19. Bae, Y.; Nishiyama, N.; Kataoka, K. In vivo antitumor activity of the folate-conjugated ph-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug. Chem. 2007, 18, 1131-1139.
20. Kano, M.R.; Bae, Y.; Iwata, C.; Morishita, Y.; Yashiro, M.; Oka, M.; Fujii, T.; Komuro, A.; Kiyono, K.; Kaminishi, M. et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of tgf-β signaling. Proc. Natl. Acad. Sci. USA 2007, 104, 3460-3465.
21. Alani, A.W.G.; Bae, Y.; Kwon, G.S. Synthesis and characterization of a micellar drug carrier for the metronomic delivery of paclitaxel. J. Control. Release 2008, 132, e19-e20.
22. Bae, Y.; Alani, A.W.G.; Rockich, N.C.; Lai, T.S.Z.C.; Kwon, G.S. Mixed ph-sensitive polymeric micelles for combination drug delivery. Pharm. Res. 2010, 27, 2421-2432.
23. Ponta, A.; Bae, Y. Peg-poly(amino acid) block copolymer micelles for tunable drug release. Pharm. Res. 2010, 27, 2330-2342.
24. Alani, A.W.G.; Bae, Y.; Rao, D.A.; Kwon, G.S. Polymeric micelles for the ph-dependent controlled, continuous low dose release of paclitaxel. Biomaterials 2010, 31, 1765-1772.
25. Lee, H.J.; Bae, Y. Cross-linked nanoassemblies from poly(ethylene glycol)-poly(aspartate) block copolymers as stable supramolecular templates for particulate drug delivery. Biomacromolecules 2011, 12, 2686-2696.
26. Shin, H.C.; Alani, A.W.; Rao, D.A.; Rockich, N.C.; Kwon, G.S. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J. Control. Release 2009, 140, 294-300.